Merrimack Pharmaceuticals to Present at the J.P. Morgan SMid Cap Conference

[at noodls] – CAMBRIDGE, Mass., Nov. 19, 2012 (GLOBE NEWSWIRE) — Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy, President & CEO, is scheduled to present at the J.P. Morgan SMid Cap … more

View todays social media effects on MACK

View the latest stocks trending across Twitter. Click to view dashboard